Article Information
History
- May 17, 2017.
Article Versions
- You are currently viewing Version 1 of this article (May 17, 2017 - 14:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Venu Pullabhatla1*,
- Amy L. Roberts2*,
- Myles J. Lewis3,
- Daniele Mauro3,
- David L. Morris2,
- Christopher A. Odhams2,
- Philip Tombleson2,
- Ulrika Liljedahl4,
- Simon Vyse2,7,
- Michael A. Simpson2,
- Sascha Sauer5,8,
- Emanuele de Rinaldis1,
- Ann-Christine Syvänen4 and
- Timothy J. Vyse2,6,9
- 1NIHR GSTFT/KCL Comprehensive Biomedical Research Centre, Guy’s & St. Thomas’ NHS Foundation Trust, London, UK
- 2Division of Genetics and Molecular Medicine, King’s College London, London, UK
- 3Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
- 4Department of Medical Sciences, Uppsala University, Uppsala, Sweden
- 5Max Planck Institute for Molecular Genetics, Berlin, Germany
- 6Division of Immunology, Infection and Inflammatory Disease, King’s College London, London, UK
- 7Current address: Division of Cancer Biology, The Institute of Cancer Research, London, UK
- 8Current address: Max Delbrück Centre for Molecular Medicine (BIMSB/BIH), Berlin, Germany
- ↵9Corresponding author: timothy.vyse{at}kcl.ac.uk
↵* Contributed equally to this work